Flavors and fragrances maker IFF's Q3 sales beat; low end of 2026 outlook raised

By Reuters News


Overview

  • Flavors and fragrances maker's Q3 sales rose 4%, beating analyst expectations

  • Adjusted EPS for Q3 beat analyst expectations

  • Company completed $500 mln share repurchase and raised low end of full-year guidance


Outlook

  • IFF raises low end of 2026 sales outlook to $7.5 bln-$7.6 bln from $7.4 bln-$7.6 bln

  • Company lifts 2026 adjusted operating EBITDA guidance to $1.55 bln-$1.60 bln from $1.53 bln-$1.60 bln

  • IFF expects 2026 comparable currency neutral sales growth of 3%-4%, up from 2%-4% previously


Result Drivers

  • VOLUME GROWTH - Co said broad-based volume growth drove sales increases across all divisions, with Taste and Scent segments seeing mid-single digit gains and Health & Biosciences posting low-single digit growth

  • SEGMENT PERFORMANCE - Taste and Scent segments delivered strong top- and bottom-line results, while Health & Biosciences improved modestly, according to CEO Erik Fyrwald

  • COSTS AND REINVESTMENT - Co said higher costs and reinvestments in Health & Biosciences are expected to impact profitability, particularly in Q4


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Sales

Beat

$1.94 bln

$1.91 bln (13 Analysts)

Q3 Adjusted EPS

Beat

$0.83

$0.80 (14 Analysts)

Q3 Net Loss

$55 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 15 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the food processing peer group is "buy"

  • Wall Street's median 12-month price target for International Flavors & Fragrances Inc. is $100.00, about 5.7% above its November 2 closing price of $94.63

  • The stock recently traded at 25 times the next 12-month earnings vs. a P/E of 17 three months ago


Reuters Recommended Reads

  • Nov 3 - Unilever targets $1.12 billion savings in home, personal care pivot

  • Nov 3 - Keurig Dr Pepper flags slower fourth-quarter coffee profits as shoppers trade down

  • Nov 2 - Clorox Q1 results beat estimates; expects FY adj EPS near low end of guidance range


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.